Abstract:Purpose: The potent anti-cancer capability of a novel CPT derivarate, 10-methoxy-9-nitrocamptothecin (MONCPT), has been demonstrated in our previous studies. The present study focuses on the in vitro and in vivo anti-cancer activities, the cell cycle arrest- and apoptosis-induction abilities of MONCPT on human bladder uroepithelial carcinoma 5637 cell line. Materials and Methods: MTT assay and flow cytometric analyses were employed to evaluate the cell proliferation, cell cycle distribution and apoptosis of MONCPT-treated 5637 cells. Using 5637 xenografted nuce mice models, the in vivo anti-cancer capability of MONCPT were examined, as indicated by the decreased tumor volume and tumor weight. The effect of MONCPT on some of the key regulators of G2/M checkpoint and apoptosis, including CDKI-CDK-cyclin cascade, Kip1/p27 and Cip1/p21, PARP were examined using western blotting. Results: The more potent anti-tumor activities of MONCPT than SN-38 against 5637 cells were indicated by the IC50 value (48 h) of 226.7 +/- 0.5 nM and 2031.0 +/- 0.5 nM, respectively. MONCPT treatment (0.1 mu M) for 24 h caused the increment of G2/M population from 7.94% to 75.52%, indicating that MONCPT significantly triggered G2/M arrest. Moreover, MONCPT exposure (0.1 mu M, 24 h) caused down-regulation of CDK7, p-Cdc2, and cyclinB1. Treatment with MONICPT (0.1 mu M) for 48 h obviously induced apoptosis of 5637 cells, which was revealed by the accumulation of Annexin V-positive cells. The superior anti-tumor capabilities of MONCPT were further demonstrated in the human 5637 xenograft-bearing mice model. The administration of MONCPT at the dosages of 5, 10, 20 mg/kg for 15 days significantly inhibited the tumor growth with the inhibition rates of 64.8%, 86.2% and 96.5%, respectively. Conclusion: The present study displayed the significant in vitro anti-proliferative abilities of MONCPT on human ladder cancer 5637 cells, and in vivo tumor-inhibitory activities on xenograft models. In addition, MONCPT was demonstrated to induce G2/M arrest and apoptosis in 5637 cells. Our findings provide evidences for the anti-tumor activity of MONCPT in the ongoing preclinical assessment.

[10-Hydroxycamptothecin induces apoptosis in human T24 urinary bladder cancer cells].

Antitumor mechanisms of 10-hydroxycamptothecin against T 24 human urinary bladder cancer cells

Mechanism of Apoptotic Induction on T24 Cells by Honokiol and Its Synergistic Anticancer Effect in Combination with Hydroxycamptothecin

AMPK-mTOR-ULK1 axis activation-dependent autophagy promotes hydroxycamptothecin-induced apoptosis in human bladder cancer cells

[Inhibition Effect of Topotecan on Human Myelodysplastic Syndrome Cells in Vitro and in Vivo].

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells

Homoharringtonine induces apoptosis and growth arrest in human myeloma cells.

10-Hydroxycamptothecin induces apoptosis in human neuroblastoma SMS-KCNR cells through p53, cytochrome c and caspase 3 pathways.

Hydroxycamptothecin Induced Apoptosis in 5637 Cells Line:An In-vitro Model for High-risk Superficial Bladder Cancer

Antiangiogenic potential of 10-hydroxycamptothecin

Apoptotic mechanism of pirarubicin against bladder cancer

Heptaphylline suppresses the proliferation and migration of human bladder cancer cells via induction of intrinsic apoptosis, autophagy and inhibition of -catenin signalling pathway

Genistein sensitizes bladder cancer cells to HCPT treatment in vitro and in vivo via ATM/NF-κB/IKK pathway-induced apoptosis

INDUCTION OF APOPTOSIS IN HUMAN LUNG CANCER CELL LINE SPC A 1 BY HYDROXYL CAMPTOTHECINUM

MONCPT exerts anti-cancer activities via inducing G2/M arrest and apoptosis in human bladder cancer.

The Cytotoxic Effect,cell Cycle Perturbations and Apoptosis by Gemcitabine in Human Bladder Cancer Lines

Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells.

Mechanisms Involved in Hydroxycamptothecin‐induced Apoptosis of Gastric Cancer Cells

Hydroxycamptothecin-Induced Apoptotic Gene Expression Profiling by Pcr Array in Human Tenon'S Capsule Fibroblasts

Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer

Effects of EGCG on Apoptosis of Human Bladder Carcinoma T24 Cells